Aortic Valve Plasty during Correction of Combined Mitral-Aortic Valve Diseases

Keywords: combined mitral-aortic valve diseases, mitral valve replacement, aortic valve plasty, cardiopulmonary bypass

Abstract

The aim. To study the experience of valve-preserving operations on the aortic valve combined with plasty of the left atrium in patients with atriomegaly (the first clinical experience).

Materials and methods. The study included 1890 patients with combined mitral-aortic valve diseases (CMAVD) who were undergoing surgical treatment at the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine in the period from 01/01/2006 to 01/01/2020. Of these, 156 (8.3%) underwent reconstructive intervention on the aortic valve during mitral valve replacement (MVR).

Valve sparing procedures performed:
- aortic valvotomy (93 patients);
- aortic valvotomy + debridgment (30 patients);
- aortic valvotomy + leaflet plication (4 patients);
- removal of vegetation from the aortic valve (7 patients);
- applying a patch of autopericardium on a leaflet (7 patients);
- carpentier aortic valve annuloplication (2 patients);
- aortic valve debridgment (12 patients);
- aortic valve decalcification + Morrow operation (1 patient).

All operations were performed under conditions of cardiopulmonary bypass (CPB) and moderate hypothermia (28-32 °C). Myocardial protection was carried out mainly by means of ante-retrograde pharmaco-cold cardioplegia with Custodiol solution in combination with external cooling of the heart.

The time of aortic clamping was 82.4 ± 12.1 minutes, and the time of CPB was 117.5 ± 21.5 minutes. In 689 (78.4%) operated patients, blood loss was within 450 ml. In 29 (18.6%) patients, donor blood components were not used at the hospital stage.

Conclusions. On the basis of the clinical experience gained, it seems appropriate to recommend reconstructive interventions on aortic valve with moderate changes in it in order to avoid traumatic two-valve prosthetics in the correction of combined mitral-aortic defects and to improve the survival rates and stability of good results.

References

  1. Bonow R, Braunwald E. Valvular Heart Disease. In: Zipes D, Libby P, Bonow R, Braunwald E, editors. Braunwald’s Heart Disease. 7th edition. Elsevier Saunders; 2005. p. 1572-7.
  2. Попов ВВ. Хирургическая коррекция сочетанных митрально-аортальных пороков сердца в условиях искусственного кровообращения (монография). Київ: Науковий світ; 2006.
  3. Popov VV. [Surgical correction of combined mitral-aortic heart diseases in conditions of artificial circulation]. Kyiv; 2006. Russian.
  4. Pagni S, Ganzel BL, Singh R, Austin EH, Mascio C, Williams ML, et al. Clinical outcome after triple-valve operations in the modern era: are elderly patients at increased surgical risk? Ann Thorac Surg. 2014 Feb;97(2):569-76. https://doi.org/10.1016/j.athoracsur.2013.07.083
  5. Panda BR, Shankar R, Kuruvilla KT, Philip MA, Thankachen R, Shukla V, et al. Combined mitral and aortic valve replacement for rheumatic heart disease: fifteen-year follow up and long-term results. J Heart Valve Dis. 2009 Mar;18(2):170-9.
  6. Leone A, Fortuna D, Gabbieri D, Nicolini F, Contini GA, Pigini F, et al. Triple valve surgery: results from a multicenter experience. J Cardiovasc Med (Hagerstown). 2018 Jul;19(7):382-388. https://doi.org/10.2459/JCM.0000000000000665
  7. Davarpasand T, Hosseinsabet A. Triple valve replacement for rheumatic heart disease: short- and mid-term survival in modern era. Interact Cardiovasc Thorac Surg. 2015 Mar;20(3):359-64. https://doi.org/10.1093/icvts/ivu400
  8. Sytar L, Popov V, Beshlyaga V. Risk-factors in surgery of combined mitral-aortic valve diseases replacement [abstract]. J Cardiovasc Surg. 2005;46(3 Suppl 1):61.
  9. Popov V, Pukas K, Beshlyaga V, Rybacova, Lazorishinetz V. Risk factors for replacement and plastic procedure in combined mitral-aortic valve disease [abstract]. J Cardiovasc Surg. 2018;59(3 Suppl 2):29.
  10. Talwar S, Mathur A, Choudhary SK, Singh R, Kumar AS. Aortic valve replacement with mitral valve repair compared with combined aortic and mitral valve replacement. Ann Thorac Surg. 2007 Oct;84(4):1219-25. https://doi.org/10.1016/j.athoracsur.2007.04.115
  11. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57-185. https://doi.org/10.1016/j.jacc.2014.02.536
  12. Vohra HA, Whistance RN, Hechadi J, de Kerchove L, Fuller H, Noirhomme P, et al. Long-term outcomes of concomitant aortic and mitral valve repair. J Thorac Cardiovasc Surg. 2014 Aug;148(2):454-60. https://doi.org/10.1016/j.jtcvs.2013.10.016
Published
2020-12-16
How to Cite
1.
Bolshak O, Boukarim V, Vitovskiy R, Bakhovska Y, Popov V. Aortic Valve Plasty during Correction of Combined Mitral-Aortic Valve Diseases. ujcvs [Internet]. 2020Dec.16 [cited 2024Dec.22];(4 (41):30-4. Available from: https://cvs.org.ua/index.php/ujcvs/article/view/380